Sathya Bhandari, MD
Pain Medicine · Corinth, TXNPI 1356419980
Payments from drug & device makers
What this record shows
This record is dominated by speaking fees: $79,250 of the $108,275 with a category attached, or 73.2%. Boston Scientific accounts for 93.2% of it on its own, with 32 other manufacturers making up the rest. Among pain medicine clinicians in TX with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 460 payments — averaging $235.38 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Boston Scientific$101K
- Vertiflex, Inc.$1K
- Abbott$1K
- Nevro Corp.$865
- Spinal Simplicity, LLC$673
- Saluda Medical Americas, Inc.$604
- plus $3K from 27 others
What the payments were for
- Consulting fees$5,5005%
- Speaking & faculty fees$79,25073%
- Travel & lodging$11,89511%
- Food & beverage$11,56911%
- Education$610%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Boston Scientific | 217 | $100,922 |
| Vertiflex, Inc. | 11 | $1,041 |
| Abbott | 41 | $1,032 |
| Nevro Corp. | 13 | $865 |
| Spinal Simplicity, LLC | 10 | $673 |
| Saluda Medical Americas, Inc. | 12 | $604 |
| AbbVie(2 entities) | 26 | $411 |
| Si-bone, Inc. | 14 | $394 |
| Curonix LLC | 6 | $348 |
| Stimwave Technologies Incorporated | 5 | $292 |
| Collegium Pharmaceutical, Inc. | 12 | $229 |
| Sentynl Therapeutics, Inc. | 32 | $212 |
| Stryker | 4 | $193 |
| Pfizer | 8 | $183 |
| Lundbeck LLC | 7 | $133 |
| Scilex Pharmaceuticals Inc. | 8 | $129 |
| Azurity Pharmaceuticals, Inc. | 6 | $105 |
| Medtronic | 3 | $83 |
| Avanos Medical | 3 | $53 |
| Lilly USA, LLC | 3 | $51 |
| SPR Therapeutics, Inc | 2 | $48 |
| Averitas Pharma Inc. | 2 | $46 |
| Arbor Pharmaceuticals, Inc. | 3 | $44 |
| Bioventus LLC | 2 | $39 |
| Almatica Pharma LLC | 2 | $26 |
| Hydrocision, Inc. | 1 | $21 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 1 | $18 |
| Amgen | 1 | $17 |
| Tonix Medicines, Inc. | 1 | $16 |
| Kowa Pharmaceuticals America, Inc. | 1 | $15 |
| Currax Pharmaceuticals LLC | 1 | $14 |
| Novartis | 1 | $12 |
| Forte Bio-pharma LLC | 1 | $5 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- WaveWriter Alpha Prime 16$45,140
- GENERAL - THERAPIES$7,879
- Intracept$5,642
- Superion ISS$762
- SPECTRA WAVEWRITER$529
- HA MINUTEMAN G3-R$487
- Senza Spinal Cord Stimulation System$459
- Evoke$273
- StimQ Receiver Stimulator Kit Channel A US w Receiver$256
- StimQ Freedom-4A Receiver Kit Channel A US w/ Receiver$256
- StimQ Freedom 8A Receiver Kit Channel A US w Receiver$256
- Freedom 4A Receiver Kit Channel A US w Receiver$256
- Freedom 8A Receiver Kit Channel A US w Receiver$256
- Proclaim Family of SCS IPGs$192
- GENERAL PAIN MANAGEMENT$139
- PNS FREEDOM-4A PERMANENT NEUROSTIMULATOR RECEIVER KIT CHANNEL A$123
- WAVEWRITER ALPHA$107
How this compares
$108,275 in reported general payments places this provider in the 95th percentile of 583 pain medicine providers in Texas.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| BotoxOnabotulinumtoxina | 17 | $16,082 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 437 | $9,817 |
| OxycontinOxycodone Hcl | 13 | $7,629 |
| ZtlidoLidocaine | 12 | $4,860 |
| Buprenorphine | 23 | $3,137 |
| Morphine Sulfate ErMorphine Sulfate | 46 | $1,821 |
| Oxycodone-AcetaminophenOxycodone Hcl/Acetaminophen | 71 | $1,389 |
| Gabapentin | 104 | $1,267 |
| Oxycodone Hcl | 52 | $983 |
| Pregabalin | 41 | $944 |
| Fentanyl | 14 | $781 |
| Acetaminophen-CodeineAcetaminophen With Codeine | 54 | $771 |
| Methadone Hcl | 29 | $339 |
| Celecoxib | 38 | $334 |
| Methocarbamol | 24 | $328 |
Paid to pharmacies, not to this prescriber.
Companies that both paid and supply prescribed drugs
These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.
| Company | Paid to this provider | Part D cost of their drugs |
|---|---|---|
| AbbVieBotox | $411 | $16,08217 claims |
| Scilex Pharmaceuticals Inc.Ztlido | $129 | $4,86012 claims |
Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 95th percentile of 583 pain medicine providers in Texas.
Other pain medicine in Corinth
- Melissa MurphyGrapevine$653K
- Shiraz YazdaniLubbock$514K
- Aaron CalodneyTyler$296K
- Candice BurnetteSugar Land$265K
- Ashley Bailey-ClassenFort Worth$244K
- Grant ChenHouston$175K
- Gunjan PatelHouston$166K
- Anthony BergRockwall$165K
- Puneet SayalCorpus Christi$153K
- Eduardo GarciaWebster$147K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.